These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20578219)

  • 21. Closure of the patent foramen ovale with dedicated Amplatzer occluders: Closing in on a mechanical vaccination.
    Meier B
    Catheter Cardiovasc Interv; 2008 Jul; 72(1):80-1. PubMed ID: 18561159
    [No Abstract]   [Full Text] [Related]  

  • 22. Interatrial shunt closure devices in patients with nickel allergy.
    Reddy BT; Patel JB; Powell DL; Michaels AD
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):647-51. PubMed ID: 19777603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two cases of pericardial tamponade due to nitinol wire fracture of a gore septal occluder.
    Kumar P; Orford JL; Tobis JM
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):219-224. PubMed ID: 31696617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac perforation during patent foramen ovale closure sealed with an amplatzer PFO occluder.
    Chiam PT; Schneider LM; Ruiz CE
    J Invasive Cardiol; 2008 Dec; 20(12):665-8. PubMed ID: 19057033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late tamponade secondary to aortic root perforation by BioSTAR septal closure device.
    Cikirikcioglu M; Cherian S; Lerch R; Licker MJ; Roffi M; Bonvini RF; Kalangos A
    Ann Thorac Surg; 2011 Feb; 91(2):604-6. PubMed ID: 21256328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late thrombus formation on the Helex septal occluder after double-lung transplant.
    Zaidi AN; Cheatham JP; Galantowicz M; Astor T; Kovalchin JP
    J Heart Lung Transplant; 2010 Jul; 29(7):814-6. PubMed ID: 20382035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fracture of a GORE HELEX septal occluder following PFO closure in a diver.
    Scott P; Wilson N; Veldtman G
    Catheter Cardiovasc Interv; 2009 May; 73(6):828-31. PubMed ID: 19180658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double standards in the world of ASD and PFO management: closure for paradoxical embolism.
    Carroll JD
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1070-1. PubMed ID: 19950331
    [No Abstract]   [Full Text] [Related]  

  • 30. Implantation of a second Amplatzer device to eliminate residual shunt after transcatheter patent foramen ovale closure.
    Chessa M; Citro R; Butera G; Provenza G; Bossone E; Carminati M
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):736-7. PubMed ID: 19483639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
    Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed perforation of a transcatheter patent foramen ovale occluder 10 years after implantation.
    Vitanova K; Cleuziou J; Vogt M; Nöbauer C; Schreiber C; Lange R; Voss B
    Ann Thorac Surg; 2015 Feb; 99(2):700-1. PubMed ID: 25639414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late presentation of CardioSEAL PFO closure device fracture and thrombus formation three years after device implantation.
    Narayan V; Puri P; Mehra AO
    J Invasive Cardiol; 2008 Aug; 20(8):E247-9. PubMed ID: 18688073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early experience with a simplified technique for transcatheter closure of the patent foramen ovale.
    Kutty S; Nykanen DG; Zahn EM
    Heart Lung Circ; 2009 Dec; 18(6):384-7. PubMed ID: 19783211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of percutaneous closure of patent foramen ovale: comparison among three commonly used occluders.
    Thaman R; Faganello G; Gimeno JR; Szantho GV; Nelson M; Curtis S; Martin RP; Turner MS
    Heart; 2011 Mar; 97(5):394-9. PubMed ID: 21296783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of a domestic left-disk-coated atrial septal occluder on treating patent foramen Ovale in a miniswine model].
    Huang YG; Zhang CJ; Huang T; Huang WH; Huang XS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Oct; 37(10):936-8. PubMed ID: 20137548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late cardiac perforation after transcatheter closure of patent foramen ovale.
    Cecconi M; Quarti A; Bianchini F; Bucari S; Costantini C; Giovagnoni A; Perna GP
    Ann Thorac Surg; 2006 Jun; 81(6):e29-30. PubMed ID: 16731110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimal invasive retrieval of dislodged Amplatzer occluder with subsequent impediments.
    Born P; Eckstein F; Buser P; Reuthebuch O
    Thorac Cardiovasc Surg; 2013 Jun; 61(4):330-2. PubMed ID: 22535671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late cardiac perforation after transcatheter closure of patent foramen ovale mimicking acute type a aortic dissection.
    Girdauskas E; Diab M; Secknus MA; Borger MA; Kuntze T
    Ann Thorac Surg; 2010 May; 89(5):1649-51. PubMed ID: 20417804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Very late migration to and retrieval of an Amplatzer patent foramen ovale occlusion device from the abdominal aortic carrefour.
    Musuraca G; Agostoni P; Boldi E; Imperadore F; Terraneo C; Broso GP
    J Cardiovasc Med (Hagerstown); 2018 Aug; 19(8):459-461. PubMed ID: 29894354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.